Article Name Medtech innovation
As regulatory shifts accelerate, next-generation non-animal models must rapidly evolve to ensure safety, efficacy, and innovation in human drug development.
23rd July, 2025
How high-quality, integrated datasets are transforming drug repurposing from opportunistic discovery to systematic innovation in therapeutic development.
23rd July, 2025
Landmark integration of in vitro organ-on-a-chip and computational modeling marks a pivotal advancement in disease simulation, drug testing, and personalized medicine.
23rd July, 2025
New patent strengthens global IP portfolio for noninvasive lung cancer detection platform, expanding bioAffinity’s reach into international markets
23rd July, 2025
New AI-Enabled Technology Aims to Personalize Fluid Management and Improve Outcomes Across Hospital Network
23rd July, 2025
Danish multicenter study confirms clinical utility of genomic test in identifying low-risk stage I–II melanoma patients, advancing precision in surgical decision-making
22nd July, 2025
Patent strengthens company’s IP portfolio as it expands innovative treatments for chronic pain, oncology, and other high-need conditions
22nd July, 2025
Recognition highlights breakthrough technology designed to enhance continuous, child-friendly monitoring in clinical and home settings
22nd July, 2025
New devices designed to streamline and personalize HYQVIA® administration for patients receiving subcutaneous immune globulin therapy
22nd July, 2025
Approval now includes children as young as two, pregnant individuals, and people with type 2 diabetes across Europe
22nd July, 2025
Innovative device designed to maintain sinus patency post-surgery, enhancing healing and patient comfort without the need for removal
22nd July, 2025
Pivotal trial launches to evaluate XVIVO’s portable perfusion device designed to optimize heart preservation and transplantation outcomes across the U.S.
21st July, 2025
New global report explores the transformative role of digital platforms, AI, and connectivity in reshaping surgical precision, training, and patient outcomes across healthcare systems.
21st July, 2025
NDA for TAR-200 targets high-risk non-muscle invasive bladder cancer, highlighting potential to transform treatment for patients unresponsive to BCG therapy
21st July, 2025
St. David's Medical Center pioneers clinical use of innovative wireless EP solution, marking a new chapter in minimally invasive cardiac care.
21st July, 2025
Renowned oncology expert joins to support advancement of next-generation cancer diagnostics and therapeutics.
21st July, 2025
The NMPA approval of the ZEISS CLARUS 700 represents a major leap forward in ultra-widefield retinal imaging, offering high-resolution, true color visualization to support early detection and management of complex eye diseases across China.
21st July, 2025
Certification Advances Global Access to Comprehensive Genetic Testing and Precision Medicine Solutions in Europe
18th July, 2025
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer